Status:
COMPLETED
A Phase I Study of iPS Cell Generation From Patients With COPD
Lead Sponsor:
Mayo Clinic
Conditions:
Thoracic Diseases
Respiratory Tract Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
As part of the long-term goal of successfully implementing tissue regeneration strategies in an individualized manner for patients with thoracic diseases including, but not limited to: cystic fibrosis...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Undergoing Thoracic Surgery at the Mayo Clinic Rochester
- Presence of a Thoracic Disease
Exclusion
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 28 2014
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT01860898
Start Date
September 1 2009
End Date
October 28 2014
Last Update
September 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905